About Alpha-tocopherol transfer protein
Alpha-tocopherol transfer protein (TTPA) is a protein
from Homo sapiens identified by UniProt accession
P49638, 278 residues long.
MolForge cross-references it against 0 known binders and
153 disease associations.
Target properties
| Protein name | Alpha-tocopherol transfer protein |
| UniProt accession | P49638 |
| Gene | TTPA |
| Organism | Homo sapiens |
| Length | 278 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (153)
Diseases linked to this target (Open Targets).
- Ataxia with vitamin E deficiency · score 0.82
- familial isolated deficiency of vitamin E · score 0.80
- hereditary ataxia · score 0.46
- Abnormal central motor function · score 0.27
- blood protein measurement · score 0.24
- calcium measurement · score 0.22
- diet measurement · score 0.19
- genetic disorder · score 0.19
- C-reactive protein measurement · score 0.09
- Female infertility due to fertilization defect · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P49638-F1 | alphafold | PREDICTED | 94.15 | — |
Amino-acid sequence (278 residues)
MAEARSQPSA GPQLNALPDH SPLLQPGLAA LRRRAREAGV PLAPLPLTDS FLLRFLRARD FDLDLAWRLL KNYYKWRAEC PEISADLHPR SIIGLLKAGY HGVLRSRDPT GSKVLIYRIA HWDPKVFTAY DVFRVSLITS ELIVQEVETQ RNGIKAIFDL EGWQFSHAFQ ITPSVAKKIA AVLTDSFPLK VRGIHLINEP VIFHAVFSMI KPFLTEKIKE RIHMHGNNYK QSLLQHFPDI LPLEYGGEEF SMEDICQEWT NFIMKSEDYL SSISESIQ
Explore Alpha-tocopherol transfer protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets